{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T19:11:55Z","timestamp":1790190715356,"version":"4.1.0"},"reference-count":19,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,2]]},"abstract":"<jats:sec>\n                    <jats:title>Purpose:<\/jats:title>\n                    <jats:p>To study the impact of moderate and severe primary open-angle glaucoma (POAG) on the quality of life (QoL) due to activity limitation using glaucoma-specific questionnaires.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>\n                      This cross-sectional study enrolled 122 participants, 50% (\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      = 61) being controls and 50% were diagnosed cases of moderate\/severe POAG. Three orally administered glaucoma-specific QoL instruments were used: Glaucoma Activity Limitation (GAL-9), Glaucoma Quality of Life (GQL-15), and Viswanathan questionnaires. The questions related to activity limitation were identified and analyzed for each questionnaire separately.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      The mean age of the participants was 61.04 \u00b1 9.88 years and a majority were males (64.8%,\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      = 79). The mean scores in controls, moderate glaucoma, and severe POAG patients for GAL-9 questionnaire were 9.77 \u00b1 1.36 (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.44), 13.75 \u00b1 4.76 (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.001), and 23.45 \u00b1 5.62 (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.001), for GQL-15, these were 16.39 \u00b1 2.18 (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.5), 22.75 \u00b1 7.89 (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.001), and 39.34 \u00b1 9.42 (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.001), respectively, while for the Viswanathan questionnaire, they were 9.49 \u00b1 0.94 (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.38), 7.91 \u00b1 1.59 (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.001), and 4.41 \u00b1 2.20 (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.001), respectively. The GQL-15 and GAL-9 questionnaires concluded that activity limitation pertaining to dark adaptation-related tasks affected the QoL the most in moderate as well as severe POAG (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.001). Using the Viswanathan questionnaire, it was observed that the peripheral vision-related activity limitation was most significant for the decrease in QoL in moderate POAG while near vision-related activity limitation affected the QoL the most in severe POAG (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.001).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>All three questionnaires concluded that the activity limitation due to moderate and severe glaucoma has a negative impact on the QoL. The limitation of the tasks involving dark adaptation\/glare and peripheral vision has the most significant impact on the QoL in moderate glaucoma. As the disease progresses to a severe category, the limitation of activities requiring central and near vision causes the most significant worsening in QoL.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/ijo.ijo_1687_21","type":"journal-article","created":{"date-parts":[[2022,2,16]],"date-time":"2022-02-16T07:51:02Z","timestamp":1644997862000},"page":"552-557","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":10,"title":["Impact of moderate and severe primary open-angle glaucoma on quality of life due to activity limitation"],"prefix":"10.4103","volume":"70","author":[{"given":"Shifali","family":"Nayyar","sequence":"first","affiliation":[{"name":"Department of Ophthalmology, Government Medical College and Hospital, Chandigarh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suresh","family":"Kumar","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Government Medical College and Hospital, Chandigarh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Obaidur","family":"Rehman","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Government Medical College and Hospital, Chandigarh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parul","family":"Ichhpujani","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Government Medical College and Hospital, Chandigarh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ekta","family":"Singla","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Government Medical College and Hospital, Chandigarh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2022,1,27]]},"reference":[{"key":"R1-20251006","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.spen.2019.05.006","article-title":"The assessment of visual function and functional vision","volume":"31","author":"Bennett","year":"2019","journal-title":"Semin Pediatr Neurol"},{"key":"R2-20251006","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1007\/s12325-016-0333-6","article-title":"Quality of life in glaucoma:A review of the literature","volume":"33","author":"Quaranta,","year":"2016","journal-title":"Adv Ther"},{"key":"R3-20251006","doi-asserted-by":"crossref","first-page":"416","DOI":"10.4103\/ijo.IJO_847_17","article-title":"The impact of primary open-angle glaucoma:Quality of life in Indian patients","volume":"66","author":"Kumar","year":"2018","journal-title":"Indian J Ophthalmol"},{"key":"R4-20251006","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.4103\/ijo.IJO_295_18","article-title":"Correlation of central field index (10\u20132 visual field analysis) and activity limitation with increasing severity of glaucoma using glaucoma activity limitation-9 questionnaire","volume":"66","author":"Daruka","year":"2018","journal-title":"Indian J Ophthalmol"},{"key":"R5-20251006","doi-asserted-by":"crossref","first-page":"9","DOI":"10.5005\/jp-journals-10078-1242","article-title":"Evaluation of vision-related quality of life in patients with glaucoma:A hospital-based study","volume":"13","author":"Dhawan","year":"2019","journal-title":"J Curr Glaucoma Pract"},{"key":"R7-20251006","first-page":"112","article-title":"Primary glaucomas. Gonioscopy, ophthalmoscopy and perimetry","volume":"64","author":"Shaffer","year":"1960","journal-title":"Trans Am Acad Ophthalmol Otolaryngol"},{"key":"R8-20251006","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1136\/bjo.2005.083360","article-title":"Disc damage likelihood scale","volume":"90","author":"Henderer","year":"2006","journal-title":"Br J Ophthalmol"},{"key":"R9-20251006","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1471-2415-8-2","article-title":"Which quality of life score is best for glaucoma patients and why?","volume":"8","author":"Severn","year":"2008","journal-title":"BMC Ophthalmol"},{"key":"R10-20251006","doi-asserted-by":"crossref","first-page":"6971","DOI":"10.1167\/iovs.11-7423","article-title":"Reengineering the glaucoma quality of life-15 questionnaire with rasch analysis","volume":"52","author":"Khadka","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R11-20251006","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1001\/archopht.117.4.450","article-title":"Severity and stability of glaucoma:Patient perception compared with objective measurement","volume":"117","author":"Viswanathan","year":"1999","journal-title":"Arch Ophthalmol"},{"key":"R12-20251006","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1167\/iovs.07-0559","article-title":"Evaluation of quality of life and priorities of patients with glaucoma","volume":"49","author":"Aspinall","year":"2008","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R13-20251006","doi-asserted-by":"crossref","first-page":"5810","DOI":"10.1167\/iovs.17-22560","article-title":"Slow reading in glaucoma:Is it due to the shrinking visual span in central vision?","volume":"58","author":"Kwon","year":"2017","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R14-20251006","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1167\/iovs.12-10618","article-title":"Difficulty with out-loud and silent reading in glaucoma","volume":"54","author":"Ramulu","year":"2013","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R15-20251006","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1016\/j.ophtha.2007.02.014","article-title":"Fear of blindness in the collaborative initial glaucoma treatment study:Patterns and correlates over time","volume":"114","author":"Janz","year":"2007","journal-title":"Ophthalmology"},{"key":"R16-20251006","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/j.ophtha.2007.08.037","article-title":"Impact of visual field loss on health-related quality of life in glaucoma:The Los Angeles Latino Eye Study","volume":"115","author":"McKean-Cowdin","year":"2008","journal-title":"Ophthalmology"},{"key":"R17-20251006","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/BF00920055","article-title":"Dark adaptation in glaucomatous and nonglaucomatous optic nerve atrophy","volume":"228","author":"Jonas","year":"1990","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R18-20251006","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1038\/s41433-020-01164-8","article-title":"Glaucoma and glare","volume":"35","author":"Hamedani","year":"2021","journal-title":"Eye (Lond)"},{"key":"R19-20251006","first-page":"2803","article-title":"Mobility performance in glaucoma","volume":"40","author":"Turano","year":"1999","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R20-20251006","first-page":"1558","article-title":"Glaucoma and mobility performance:The Salisbury eye evaluation project","volume":"48","author":"Friedman","year":"2007","journal-title":"Invest Ophthalmol Vis Sci"}],"container-title":["Indian Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/ijo.IJO_1687_21","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T18:57:49Z","timestamp":1786647469000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/ijo.IJO_1687_21"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,27]]},"references-count":19,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.4103\/ijo.ijo_1687_21","relation":{},"ISSN":["0301-4738","1998-3689"],"issn-type":[{"value":"0301-4738","type":"print"},{"value":"1998-3689","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,27]]},"assertion":[{"value":"2021-06-20","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-09-21","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}